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IntrOductIOn
Induction of labour is defined as stimulation of uterine contractions 
before they occur spontaneously and its prevalence  has increased 
in the United States from 9.5% of births in 1990 to 22.1% of births 
in 2004 [1]. Although induction of labour has recently been on 
the rise for purposes of convenience or to accommodate busy 
schedules, the main reasons include prolonged pregnancies 
and  maternal and foetal indications [2]. Prolonged pregnancies 
can result in development of oligohydramnios, macrosomia, and 
intra–uterine foetal demise at a later gestational age [3]. Induction 
of labour is  thought to be advantageous for the mother or baby 
[4]. Induction of labour is directly relevant to the health related 
Millennium Development Goals (MDGs) and it may also contribute 
to lowering of caesarean section rates [5]. Labour can be induced 
by mechanical and pharmacological methods such as use of 
prostaglandins [6]  and Oxytocin [7]. Oxytocin can be used alone or 
in combination with other agents for labour induction. Propranolol 
is one of these agents which have been suggested for assisting 
labour induction [8]. In several studies, it was seen that Propranolol 
could induce contractions in the pregnant uterine musculature 
[9,10]. Propranolol, as a β-adrenergic receptor-blocking drug, 
can reversed the inhibitory effect of  β-agonist isoproterenol on 
human uterine motility [11]. In a study,  its intravenous use  once or 
twice in a 2 mg dose  was found to shorten the duration of labour 











[12]. In other study, intravenous Propranolol was found to increase 
uterine activity in pregnant and in the non-pregnant participants 
[13]. No poor effect on neonatal outcome was found  with use 
of Propranolol [11,12]. The purpose of the present study was to 
evaluate the effect of Oral Propranolol plus Oxytocin in comparison 
with Oxytocin alone on induction of labour.
MAterIAl And MethOds
This was a double blind randomized controlled trial that was 
performed at the Ilam , Mostafa Hospital, Ilam, Iran, from March 2010 
to March 2011. We studied 146 pregnant women with prolonged 
pregnancies. The eligibility criteria were singleton pregnancies with 
gestational age of 40–42 weeks of pregnancy (according to a reliable 
last menstrual period and ultrasound evaluation at first trimester), 
nulliparity, cephalic presentation, intact membrane, and Bishop’s 
score of less than [5]. Exclusion criteria were uterus contraction, 
any previous surgical operation on the uterus, sign of foetal distress, 
suspicious macrosomia, polyhydramnios, systolic blood pressure 
of <100 mmHg, pulse rates of < 60/min and more than 120/min, 
history of any known cardiac disorder, mother’s pulmonary or 
metabolic disorders, or maternal use of drugs. 
A total of 146 pregnant women were investigated in a randomized 
clinical trial, as was previously described for other clinical trial studies 
[13,14] (73 participants in each group). In the first group (Propranolol 
plus Oxytosine), a capsule consisted of 20 mg Propranolol was 
ABstrAct
Background and Aim:  Today, research on new methods  for 
preventing caesarean sections owing to labour induction, have 
been requested in obstetric practice, because of the increased 
morbidity related to caesarean section. Therefore, the aim 
of this study was to compare the effect of Oral Propranolol 
and Oxytocin versus Oxytocin only on induction of labour in 
nulliparous women. 
Material and Methods:  A double blind randomized controlled 
trial was performed at the Ilam  Mostafa Hospital, Ilam, Iran, from 
March 2010 to March 2011 on 146 nulliparous pregnant women 
who had gestational age of 40–42 weeks of pregnancy and a 
Bishop score of ≤5. Participants were divided in two groups 
(with 73 participants in each group). In the first group (placebo 
plus Oxytocin group = 73), Oxytocin was used for the induction 
of labour. In the second group (Propranolol plus Oxytocin group 
= 73 cases), before the  use of Oxytocin, 20 mg Propranolol was 
administrated orally and then the Oxytocin was initiated. Twenty 
mg Propranolol was repeated after 8 hours if  good contraction 
was not obtained.
results: The mean duration for obtaining good contractions 
was significantly shorter in the Propranolol group than in the 
placebo group,  on both the first and second day of induction 
(p<.05). The mean duration of latent phase was shorter in the 
first in Propranolol group (p<.05). In Propranolol plus Oxytocine 
group, frequency of cesarean deliveries significantly decreased 
than in the placebo plus Oxytocin group (21% versus 39.7%). 
No significant differences in neonate outcome, such as Apgar 
scores of minutes 1 and 5 and need  of admissions to NICU, 
were found between the groups (p>.05)
discussion and conclusion: Our study showed that oral 
Propranolol was effective for labour induction and that it 
could decrease the frequency of caesarean deliveries without 
producing any adverse effects on mothers or neonates.
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%) cases  delivered vaginally. Fifteen women in Propranolol plus 
Oxytocin group and twenty-nine women in placebo plus Oxytocin 
group had a caesarean deliveries because labour failed to progress 
or there were other complications and there was a significant 
difference between groups (p< 0.05). Neonatal outcome according 
to Apgar scores of minutes 1 and 5 and need  of admissions to 
NICU between two groups  have been shown in [Table/Fig-3]. Two 
newborns in Propranolol plus Oxytocin group and four newborn in 
Oxytocin alone group had an Apgar score of less than 7 at 1 minute, 
but there were no significant differences between groups.
administered and in the second group (Oxytocin plus placebo), a 
similar capsule as a placebo was administrated orally by researcher 
before beginning of induction of labour. Oral capsules were repeated 
after 8 hours if   good contraction (3 forceful contractions  within 10 
min) was not obtained. Then, induction was initiated by experienced 
midwife who knew nothing about the method of intervention; the 
patients were also blinded to it (double blind). 
Induction and the control of patients were monitored. Induction 
was initiated at a dose of 2 mIu/min and it was increased 2 mIu /
minute every 15 minutes until good contractions were obtained (3 
forceful contractions  within 10 minutes) or to a maximum dose of 
30 mIu/min; then, it was continued at this rate for 8 hours. If patients 
entered the active phase of labour (cervical dilatation = 3–4 cm), 
induction continued until delivery. If the participants did not enter 
the active phase, the induction was discontinued and the patients 
were transferred to the pre-labour ward; and on the second day, all 
interventions were performed similar to the first day. If there was no 
response to induction on the second day, a caesarean section was 
performed. Blood pressures and heart rate of the parturients and 
foetal heart rates were monitored every 15 minutes. The participants’ 
characteristics, age, primary Bishop score, gestational age, the 
number of deliveries on the first day of induction and caesarean 
sections, timing of the beginning good contractions after induction, 
duration of latent phase (interval between the beginnings of good 
contractions until cervical dilatations of 3–4 cm were obtained), type 
of delivery and Apgar scores of minutes 1 and 5, need  of admissions 
to NICU and neonatal weights were recorded and compared in the 
two groups. The participants were followed up until delivery.
stAtIstIcAl AnAlysIs
All collected data were analysed by using SPSS, version 14 (IBM, 
Armonk, NY, USA). Comparisons of means were done by t- test. A 
p-value of 0.05 was considered as statistically significant. Statistical 
comparisons were determined by using the Mann-Whitney U test, 
unpaired t-test.
ethical evaluation 
This study was undertaken with the approval of the ethics committee 
of the Ilam University of Medical Sciences. Participation in the study 
was voluntary and the participants were free to withdraw from the 
study whenever they wished. Informed consents were obtained 
from all participants before their enrolment into the study.
results
None of the 146 enrolled women withdrew from the study for 
any reason. Baseline patient characteristics  have been shown in 
[Table/Fig-1]. Participant characteristics were not different among 
groups. On the first and second days of intervention, the intervals 
between the beginning of induction and until good contractions 
were obtained were significantly shorter in the Propranolol group. 
Also, the duration of latent phase was different between groups on 
first and second days of study. The results  have been presented 
in [Table/Fig-2]. Of 146 women who were recruited for induction, 
44 (30.13 %) cases had caesarean deliveries and 102(69.87 
[table/Fig-1]: Comparison of the characteristics of participants between
 two groups








Maternal age (years) 21.5 ± 3.5 21.9 ± 2.2 0.865
Gestational age (day) 40.8 ± 1.2 20.46 ± 2.04 0.0965
BMI (kg/m)2 21.3 ± 1.24 20.46 ± 2.04 0.640
Bishop score 2.8± 0.56 2± 0.2 0.654








Interval until good contractions 
in first day, min 
176.2±11.2 190.3±21.4 0.000
Interval until good contractions 
in second day, min    
113.5±.9.2 185±28.6 0.005
Duration of latent phase 
in first day min 
198.4±16.3 259.2±24.4 0.008
Duration of latent phase 









Neonatal Apgar score minute 1 8.8±.45 8.7±.5 0.987
Neonatal Apgar score minute 5 9.85±.47 9.9±.63 0.615
need to NICU ** 2(2.7%) 3(4%) 0.571
[table/Fig-2]: Comparison characteristics of the labor between groups
Continuous variables displayed as mean ± standard deviations
[table/Fig-3]: Comparison Neonatal outcome between groups
*Continuous variables displayed as mean ± standard deviations 
** Neonatal Intensive Care Unit, Number, Percent
dIscussIOn
Elective labour induction  has been introduced as main cause 
of caesarean deliveries. Now-a-days, research on new methods 
for preventing caesarean sections owing to labour induction or 
uterine hypocontractility have been requested in obstetric practice, 
because of the increased morbidity related to caesarean sections. 
Therefore, in the present study, we decided to evaluate the effect 
of Propranolol as beta adrenergic blocker on success of labour 
induction. 
One difference  in our trial, as compared  to that in other studies 
which have been performed up to now, is that we used oral form 
of Propranolol.  As per our results, Propranolol could significantly 
shorten both the timing of start of  good forceful contractions 
and duration of latent phase. Results of several studies are 
consistent with our results. In a randomized trial which was done 
by Kashanian et al., results were congruent with our those of 
study, in that they used intravenous injection of single dose 2 mg 
Propranolol before starting labour induction [8]. Palomaki et al., 
reported that in   cases of arrested labour  caused by insufficient 
power of contractions, adding propranolol to Oxytocin could 
improve the power of contractions [12]. Chimura showed that the 
use of alprenolol (a beta blocker) in vitro, produced myometrial 
stimulation of pregnant uterus in rats [15], and in another study, 
Peiker et al, showed a similar effect of Propranolol, on relaxation 
of the myometriam of non-pregnant rats in vitro, but its stimulation 
in pregnant rats [10]. In another study [16]. Propranolol inhibited 
the relaxant effect of Ritodrine in isolated myometrial strips that 
were obtained  during elective caesarean deliveries. The beta-2 
adrenergic receptor, a member of the super family of G protein-
coupled receptors [17] is distributed in numerous tissues and 
is manifested widely in the smooth muscle of the vasculature, 
trachea, bronchi and uterus. This receptor has an important 
role in smooth muscle relaxation resulting from the activation of 
www.jcdr.net Ashraf Direkvand-Moghadam et al., Comparison Effect of Oral Propranolol and Oxytocin Versus Oxytocin only on Induction of Labor
Journal of Clinical and Diagnostic Research. 2013 Nov, Vol-7(11): 2567-2569 2569
  [2] Caughey A.B., et al., Systematic review: elective induction of labor versus 
expectant  management of pregnancy. Ann Intern Med. 2009; 151(4):   252-63, 
W53-63.
  [3]  Hollis B. Prolonged pregnancy. Curr Opin Obstet Gynaecol. 2002; 14(2): 
203-7.
  [4]  Sarah J Stock, Evelyn Ferguson, Andrew Duffy, Ian Ford, James Chalmers, Jane 
E Norman, Outcomes of elective induction of labour compared with expectant 
management: population based study. BMJ. year 2012;344:e2838.
  [5]  Fawole Bukola, Nafiou Idi, Machoki M’Mimunya, Wolomby-Molondo Jean-
Jose, Mugerwa Kidza, Neves Isilda, et al. Unmet need for induction of labor 
in Africa: secondary analysis from the 2004 - 2005 WHO Global Maternal and 
Perinatal Health Survey (A cross-sectional survey). BMC Public Health. year 
2012, 12:722.
  [6]  Perry M.Y,  W.L. Leaphart. Randomized trial of intracervical versus posterior 
fornix dinoprostone for induction of labor. Obstet Gynecol. 2004; 103(1): 
13-7.
  [7]  Menticoglou S.M,   P.F. Hall, Routine induction of labour at 41 weeks gestation: 
nonsensus consensus. BJOG. 2002; 109(5):   485-91.
  [8] Kashanian M. Fekrat M, Zarrin Z, Ansari NS, A comparison between the effect 
of oxytocin only and oxytocin plus propranolol on the labor (a double blind 
randomized trial). J Obstet Gynaecol Res. 2008; 34(3):  354-8.
  [9] Kitazawa T, Nakagoshi K, Teraoka H, Taneike T: 5-HT(7) receptor and beta(2)-
adrenoceptor share in the inhibition of porcine uterine contractility in a muscle 
layer-dependent manner. Eur J Pharmacol. 2001 Dec 21;433(2-3):187-97.
[10] Peiker G. Mares J. Fleck C. Hasanova M. The effect of Propranolol (Obsidan) 
as well as Propranolol and Fenoterol (Partusisten) on the motility of the Smooth 
uterus musculature in vitro. Pharmazie. 1990; 45: 124- 25.
[11] Sanchez-Ramos L.,M.J. Quillen,  A.M. Kaunitz. Randomized trial of oxytocin 
alone and with propranolol in the management of dysfunctional labor. Obstet 
Gynaecol. 1996; 88(4 Pt 1):  517-20.
[12] Palomaki O. Uotila J. Tammela O. Kaila T. Lavapuro M. Huhtala H. et al. A 
double blind, randomized trial on augmentation of labour with a combination 
of intravenous propranolol and oxytocin versus oxytocin only. Eur J Obstet 
Gynaecol Reprod Biol. 2006; 125: 44-49.
[13]  Direkvand-Moghadam A, M Rezaeian. Increased intravenous hydration of 
nulliparas in labore. Int J Gynaecol Obstet. 2012; 118 (3): 213–15.
[14]  Direkvand-Moghadam A, A Khosravi. The impact of a novel herbal Shirazi 
Thymus Vulgaris on primary dysmenorrhea in comparison to the classical 
chemical Ibuprofen. Journal of Research in Medical Sciences. 2012; 670(7): 
668- 70.
[15] Chimura T. Effect of beta- adrenoceptor blockade on parturition and fetal 
cardiovascular and metabolic system. Nippon Sanka Fujinka Gakkai Zasshi. 
1985; 37: 691–95.
[16] Dennedy MC, Houlihan DD, McMillan H, Morrison JJ. Beta 2-and beta 
3-adrenoreceptor agonists: human Myometrial selectivity and effects on 
umbilical artery tone. Am J Obstet Gynaecol. 2002; 187: 641–47. 
[17] Pierce KL, Premont RT, Lefkowitz RJ.  Seven-transmembrane receptors. Nat 
Rev Mol Cell Biol. 2002;3:639–50.
[18]  Bulbring E, Tomito T. Catecholamine action on smooth muscle. Pharmacol Rev. 
1987; 39:49–9603;102:1445–54.
[19]  Engstrom T, Bratholm P, Vilhardt H, Christensen NJ.  Effect of pregnancy on rat 
myometrial beta2-adrenoceptor mRNA and isoproterenol-induced relaxation of 
isolated uterine strips. J Endocrinol. 1997;153:393–99.
[20] Legrand C, Maltier JP, Benghan-Eyene Y.  Rat myometrial adrenergic receptors 
in late pregnancy. Biol Reprod. 1987;37:641–50.
[21]  Chanrachakul B, Matharoo-Ball B, Turner A, Robinson G, Broughton-Pipkin F, 
Arulkumaran S, et al. Reduced expression of immunoreactive beta2-adrenergic 
receptor protein in human myometrium with labor. J Clin Endocrinol Metab. 
2003 Oct;88(10):4997-5001.
[22]  Adamsons K, De la Vega A, Santiago P. Reduction in the cesarean section 
rate in nulliparous patients after administration of intravenous propranolol. P R 
Health Sci J. 1999 Mar;18(1):5-8.
[23] Katzung BG. Basic and Clinical Pharmacology. New York: McGraw-Hill. 1998.
[24]  Ziółkowski K. Induction of Labor in Prolonged Pregnancy with Propranolol as a 
Personal Evaluation. Pol Tyg Lek. 1994; 49(8-9):184-5.
the adenylate cyclase signaling cascade [18]. Engstrom et al., 
reported that beta-2 adrenergic receptor number in pregnant 
rats decreases linearly throughout the gestational period [19]. 
However, Legrand et al., showed that the concentration of beta-2 
adrenergic receptor in pregnant rat myometrium, decreased just 6 
hours before the delivery [20]. Chanrachakul et al.,  in their study, 
concluded that diminished beta-2 adrenergic receptor levels, 
along with the apparent desensitization of the beta-2 adrenergic 
receptors at term gestation, would tend to promote myometrial 
contractility, thereby initiating labour, probably in concert with 
other mechanisms [21]. With respect  to these studies, it seems 
beta adrenergic blockers such as Propranolol can increase the 
uterine contractions in term pregnant uteri. Also, our study showed 
that use of Propranolol plus Oxytocin decreased the frequency 
of caesarean deliveries and this was confirmed several previous 
studies [11, 22]. However, these findings of other studies were not 
consistent with our findings [12]. Different dosages of Propranolol 
which were used in these studies was one possible explaination 
for this difference. The half life of Propranolol is about 2–3 hours 
and its maximal effect is about 1–1.5 hours after injection [23]. We 
used oral Propranolol that induces long-lasting effects on uterine 
contraction.
In our study, Propranolol had no adverse effects on neonates 
according to Apgar scores of minutes 1 and 5 and need  of 
admissions to NICU. According to classification of the Food and 
Drug Administration (FDA), Propranolol is in C group. Propranolol 
administration which was done for  labour stimulation  produced 
no adverse effects on foetal heart rate and general condition 
of the mother [24]. Safety of Propranolol  use in neonates has 
been shown in several studies [8,11,12]. We used 20 mg oral 
Propranolol at start of induction and it was repeated in the same 
dose after 8 hours if  good contractions were not obtained. In spite 
of the fact that oral Propranolol induces long-lasting effects, we 
found no adverse effects  in neonates. 
cOnclusIOns
 If a need  of induction of labour is considered as a sufficient indication 
for use of medication, with respect of our study, we suggested that 
Propranolol is effective  for success of labour induction and is safe 
for mother and newborn. 
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